Document is current

Sileshi, Tesemma

Telele, Nigus Fikrie

Burkley, Victoria

Makonnen, Eyasu

Aklillu, Eleni

Funding for this research was provided by:

European and Developing Countries Clinical Trials Partnership (CSA2016S-1618)

European and Developing Countries Clinical Trials Partnership (CSA2016S-1618)

European and Developing Countries Clinical Trials Partnership (CSA2016S-1618)

European and Developing Countries Clinical Trials Partnership (CSA2016S-1618)

Fogarty International Center and the National Institute of Allergy and Infectious Disease of the National Institute of Health (43 TW009127)

Fogarty International Center and the National Institute of Allergy and Infectious Disease of the National Institute of Health (43 TW009127)

Fogarty International Center and the National Institute of Allergy and Infectious Disease of the National Institute of Health (43 TW009127)

Styrelsen för Internationellt Utvecklingssamarbete (CSA2016S-1618)

Styrelsen för Internationellt Utvecklingssamarbete (CSA2016S-1618)

Styrelsen för Internationellt Utvecklingssamarbete (CSA2016S-1618)

Center of Innovative Drug Development and Therapeutic Trial for Africa

Text and Data Mining valid from 2023-07-15

Version of Record valid from 2023-07-15